Evaluation of bioluminescence-based assays of anti-malarial drug activity

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Hasenkamp, Sandra ^a   Sidaway, Adam ^a   Devine, Oliver ^a   Roye, Richard ^a   Horrocks, Paul ^a  

^a KEELE UNIVERSITY   (United Kingdom)

Author keywords

Antimalarial drug; Luciferase; Malaria; Relative rate of kill; Sybr green I

Indexed keywords

ANTIMALARIAL AGENT; LUCIFERASE;

ANTIMALARIAL ACTIVITY; ARTICLE; BIOLUMINESCENCE; CONTROLLED STUDY; DRUG DETERMINATION; FLUORESCENCE; INTERMETHOD COMPARISON; NONHUMAN; PLASMODIUM FALCIPARUM; PROTEIN EXPRESSION; SIGNAL NOISE RATIO;

ANTIMALARIALS; CELL SURVIVAL; GENES, REPORTER; HUMANS; INHIBITORY CONCENTRATION 50; LUCIFERASES; LUMINESCENT MEASUREMENTS; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; STAINING AND LABELING;

EID: 84873418636     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-58     Document Type: Article

References (26)

1. Challenges in antimalarial drug discovery. Burrows JN, Leroy D, Lotharius J, Waterson D, Future Med Chem 2011 3 1401 1412 10.4155/fmc.11.91 21879844
2. Expanding the antimalarial drug arsenal-now, but how? Grimberg BT, Mehlotra RK, Pharmaceuticals (Basel) 2011 4 681 712
3. Thousands of chemical starting points for antimalarial lead identification. Gamo FJ, Sanz LM, Vidal J, de Cozar C, Alvarez E, Lavandera JL, Vanderwall DE, Green DV, Kumar V, Hasan S, Brown JR, Peishoff CE, Cardon LR, Garcia-Bustos JF, Nature 2010 465 305 310 10.1038/nature09107 20485427
4. Chemical genetics of Plasmodium falciparum. Guiguemde WA, Shelat AA, Bouck D, Duffy S, Crowther GJ, Davis PH, Smithson DC, Connelly M, Clark J, Zhu F, Jiménez-Díaz MB, Martinez MS, Wilson EB, Tripathi AK, Gut J, Sharlow ER, Bathurst I, El Mazouni F, Fowble JW, Forquer I, McGinley PL, Castro S, Angulo-Barturen I, Ferrer S, Rosenthal PJ, Derisi JL, Sullivan DJ, Lazo JS, Roos DS, Riscoe MK, et al. Nature 2010 465 311 315 10.1038/nature09099 20485428
5. In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen. Plouffe D, Brinker A, McNamara C, Henson K, Kato N, Kuhen K, Nagle A, Adrian F, Matzen JT, Anderson P, Nam TG, Gray NS, Chatterjee A, Janes J, Yan SF, Trager R, Caldwell JS, Schultz PG, Zhou Y, Winzeler EA, Proc Natl Acad Sci USA 2008 105 9059 9064 10.1073/pnas.0802982105 18579783
6. A new molecular approach for cidal vs static antimalarial determination by quantifying mRNA levels. Bahamontes-Rosa N, Rodriguez-Alejandre A, Gonzalez-del-Rio R, Garcia-Bustos JF, Mendoza-Losana A, Mol Biochem Parasitol 2012 181 171 177 10.1016/j.molbiopara.2011.11.003 22108433
7. Activity of clinically relevant antimalarial drugs on Plasmodium falciparum mature gametocytes in an ATP bioluminescence "transmission blocking" assay. Lelievre J, Almela MJ, Lozano S, Miguel C, Franco V, Leroy D, Herreros E, PLoS One 2012 7 35019 10.1371/journal.pone.0035019 22514702
8. A murine model of falciparum-malaria by in vivo selection of competent strains in non-myelodepleted mice engrafted with human erythrocytes. Angulo-Barturen I, Jimenez-Diaz MB, Mulet T, Rullas J, Herreros E, Ferrer S, Jimenez E, Mendoza A, Regadera J, Rosenthal PJ, Bathurst I, Pompliano DL, Gómez De Las Heras F, Gargallo-Viola D, PLoS One 2008 3 2252 10.1371/journal.pone.0002252 18493601
9. Plasmodium falciparum resistance to cytocidal versus cytostatic effects of chloroquine. Paguio MF, Bogle KL, Roepe PD, Mol Biochem Parasitol 2011 178 1 6 10.1016/j.molbiopara.2011.03.003 21470564
10. P. falciparum in vitro killing rates allow to discriminate between different antimalarial mode-of-action. Sanz LM, Crespo B, De-Cozar C, Ding XC, Llergo JL, Burrows JN, Garcia-Bustos JF, Gamo FJ, PLoS One 2012 7 30949 10.1371/journal.pone.0030949 22383983
11. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Desjardins RE, Canfield CJ, Haynes JD, Chulay JD, Antimicrob Agents Chemother 1979 16 710 718 10.1128/AAC.16.6.710 394674 (Pubitemid 10082023)
12. High-throughput Plasmodium falciparum growth assay for malaria drug discovery. Baniecki ML, Wirth DF, Clardy J, Antimicrob Agents Chemother 2007 51 716 723 10.1128/AAC.01144-06 17116676 (Pubitemid 46185294)
13. Novel, rapid, and inexpensive cell-based quantification of antimalarial drug efficacy. Bennett TN, Paguio M, Gligorijevic B, Seudieu C, Kosar AD, Davidson E, Roepe PD, Antimicrob Agents Chemother 2004 48 1807 1810 10.1128/AAC.48.5.1807-1810.2004 15105139 (Pubitemid 38544393)
14. Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening. Smilkstein M, Sriwilaijaroen N, Kelly JX, Wilairat P, Riscoe M, Antimicrob Agents Chemother 2004 48 1803 1806 10.1128/AAC.48.5. 1803-1806.2004 15105138 (Pubitemid 38544392)
15. Quantitative assessment of Plasmodium falciparum sexual development reveals potent transmission-blocking activity by methylene blue. Adjalley SH, Johnston GL, Li T, Eastman RT, Ekland EH, Eappen AG, Richman A, Sim BK, Lee MC, Hoffman SL, Fidock DA, Proc Natl Acad Sci U S A 2011 108 1214 E1223 10.1073/pnas.1112037108 22042867
16. Validating a firefly luciferase-based high-throughput screening assay for antimalarial drug discovery. Che P, Cui L, Kutsch O, Cui L, Li Q, Assay Drug Dev Technol 2012 10 61 68 10.1089/adt.2011.0378 22050430
17. Plasmodium falciparum: development of a transgenic line for screening antimalarials using firefly luciferase as the reporter. Cui L, Miao J, Wang J, Li Q, Cui L, Exp Parasitol 2008 120 80 87 10.1016/j.exppara.2008.05.003 18579134
18. Identifying apicoplast-targeting antimalarials using high-throughput compatible approaches. Ekland EH, Schneider J, Fidock DA, FASEB J 2011 25 3583 3593 10.1096/fj.11-187401 21746861
19. Simple and sensitive antimalarial drug screening in vitro and in vivo using transgenic luciferase expressing Plasmodium berghei parasites. Franke-Fayard B, Djokovic D, Dooren MW, Ramesar J, Waters AP, Falade MO, Kranendonk M, Martinelli A, Cravo P, Janse CJ, Int J Parasitol 2008 38 1651 1662 10.1016/j.ijpara.2008.05.012 18590736
20. Discovery of potent small-molecule inhibitors of multidrug-resistant Plasmodium falciparum using a novel miniaturized high-throughput luciferase-based assay. Lucumi E, Darling C, Jo H, Napper AD, Chandramohanadas R, Fisher N, Shone AE, Jing H, Ward SA, Biagini GA, DeGrado WF, Diamond SL, Greenbaum DC, Antimicrob Agents Chemother 2010 54 3597 3604 10.1128/AAC.00431-10 20547797
21. Analysis of the molecular mechanisms governing the stage-specific expression of a prototypical housekeeping gene during intraerythrocytic development of P. falciparum. Wong EH, Hasenkamp S, Horrocks P, J Mol Biol 2011 408 205 221 10.1016/j.jmb.2011.02.043 21354176
22. An improved single-step lysis protocol to measure luciferase bioluminescence in Plasmodium falciparum. Hasenkamp S, Wong EH, Horrocks P, Malar J 2012 11 42 10.1186/1475-2875-11-42 22325061
23. Stage specific expression of proliferating cell nuclear antigen and DNA polymerase delta from Plasmodium falciparum. Horrocks P, Jackson M, Cheesman S, White JH, Kilbey BJ, Mol Biochem Parasitol 1996 79 177 182 10.1016/0166-6851(96) 02657-6 8855554 (Pubitemid 26241889)
24. Synchronization of Plasmodium falciparum erythrocytic stages in culture. Lambros C, Vanderberg JP, J Parasitol 1979 65 418 420 10.2307/3280287 383936 (Pubitemid 10222999)
25. Efficient site-specific integration in Plasmodium falciparum chromosomes mediated by mycobacteriophage Bxb1 integrase. Nkrumah LJ, Muhle RA, Moura PA, Ghosh P, Hatfull GF, Jacobs WR, Fidock DA, Nat Methods 2006 3 615 621 10.1038/nmeth904 16862136 (Pubitemid 44123428)
26. A simple statistical parameter for use in evaluation and validation of high throughput screening assays. Zhang JH, Chung TD, Oldenburg KR, J Biomol Screen 1999 4 67 73 10.1177/108705719900400206 10838414 (Pubitemid 29278954)